Retatrutide + Tirzepatide Blend
Triple agonist combined with a dual GIP/GLP-1 agonist for comparative incretin research. For laboratory and research use only.
Specifications
| Size | 30mg (Reta 10mg + Tirz 20mg) |
Description
Research Overview
This blend combines Retatrutide, an agonist at the GLP-1, GIP and glucagon receptors, with Tirzepatide, a dual agonist at the GIP and GLP-1 receptors. The two overlap at two of the three receptors and differ at the third, and research interest in combining them rests on that partial overlap rather than on either compound alone. Both are studied extensively in incretin and metabolic literature as reference agonists.
Specifications
- Form: Lyophilized powder
- Storage: Store the powder refrigerated (2–8°C) or frozen, protected from light and moisture, until the printed expiry. After reconstitution, keep refrigerated (do not freeze); full potency ~1 month, with a noticeable quality drop after ~6 weeks.
For laboratory and research use only. Not for human consumption. This product is not a drug, food, or cosmetic and should not be used as a substitute for medical advice or treatment.
All products are sold strictly for in-vitro research and laboratory use only. Not for human consumption. By purchasing, you agree to our research policy and confirm you are a qualified researcher.